These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 22863447)
1. Chemokine/chemokine receptor interactions contribute to the accumulation of Th17 cells in patients with esophageal squamous cell carcinoma. Chen D; Jiang R; Mao C; Shi L; Wang S; Yu L; Hu Q; Dai D; Xu H Hum Immunol; 2012 Nov; 73(11):1068-72. PubMed ID: 22863447 [TBL] [Abstract][Full Text] [Related]
2. Increased IL-17-producing CD4(+) T cells in patients with esophageal cancer. Chen D; Hu Q; Mao C; Jiao Z; Wang S; Yu L; Xu Y; Dai D; Yin L; Xu H Cell Immunol; 2012; 272(2):166-74. PubMed ID: 22082565 [TBL] [Abstract][Full Text] [Related]
3. [Changes of TRGV genes and prognosis-related chemokine/receptor gene expressions in T cell lymphoma]. Luo Q; Jin Z; Chen S; Yang L; Li B; Li W; Li Y; Wu X Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Mar; 33(3):362-366. PubMed ID: 28274317 [TBL] [Abstract][Full Text] [Related]
4. CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma. Maruyama T; Kono K; Izawa S; Mizukami Y; Kawaguchi Y; Mimura K; Watanabe M; Fujii H Dis Esophagus; 2010 Jul; 23(5):422-9. PubMed ID: 20002703 [TBL] [Abstract][Full Text] [Related]
5. Distinctive Treg associated CCR4-CCL22 expression profile with altered frequency of Th17/Treg cell in the immunopathogenesis of Pemphigus Vulgaris. Asothai R; Anand V; Das D; Antil PS; Khandpur S; Sharma VK; Sharma A Immunobiology; 2015 Oct; 220(10):1129-35. PubMed ID: 26093920 [TBL] [Abstract][Full Text] [Related]
6. CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma. Liu JY; Li F; Wang LP; Chen XF; Wang D; Cao L; Ping Y; Zhao S; Li B; Thorne SH; Zhang B; Kalinski P; Zhang Y Br J Cancer; 2015 Sep; 113(5):747-55. PubMed ID: 26284335 [TBL] [Abstract][Full Text] [Related]
7. HBV promotes the recruitment of IL-17 secreting T cells via chemokines CCL22 and CCL17. Zhang K; Liu Y; Yang X; Sun H; Shu X; Zhang Y; Cao H; Wu M; Liu N; Zou Y; Xu Q; Li G Liver Int; 2020 Jun; 40(6):1327-1338. PubMed ID: 32187823 [TBL] [Abstract][Full Text] [Related]
8. IFN-β inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis. Cheng W; Zhao Q; Xi Y; Li C; Xu Y; Wang L; Niu X; Wang Z; Chen G Mol Immunol; 2015 Mar; 64(1):152-62. PubMed ID: 25433436 [TBL] [Abstract][Full Text] [Related]
9. Differential expression profile of Th1/Th17/Th2-related chemokines and their receptors in patients with acquired bone marrow failure syndromes. Ge M; Zheng Y; Li X; Lu S; Li H; Chen F; Chen D; Shao Y; Shi J; Feng S Hum Immunol; 2013 Feb; 74(2):176-80. PubMed ID: 23200757 [TBL] [Abstract][Full Text] [Related]
10. The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease. Dohlman TH; Chauhan SK; Kodati S; Hua J; Chen Y; Omoto M; Sadrai Z; Dana R Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4081-91. PubMed ID: 23702781 [TBL] [Abstract][Full Text] [Related]
11. Recruitment of CCR6-expressing Th17 cells by CCL20 secreted from plasmin-stimulated macrophages. Li Q; Laumonnier Y; Syrovets T; Simmet T Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):593-600. PubMed ID: 23681234 [TBL] [Abstract][Full Text] [Related]
12. Preferential recruitment of Th17 cells to cervical cancer via CCR6-CCL20 pathway. Yu Q; Lou XM; He Y PLoS One; 2015; 10(3):e0120855. PubMed ID: 25768730 [TBL] [Abstract][Full Text] [Related]
13. Phenotypic and Functional Characteristics of Th17 (CD4 Gaur P; Shukla NK; Das SN Immunol Invest; 2017 Oct; 46(7):689-702. PubMed ID: 28872971 [TBL] [Abstract][Full Text] [Related]
14. Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells. Mariani M; Lang R; Binda E; Panina-Bordignon P; D'Ambrosio D Eur J Immunol; 2004 Jan; 34(1):231-40. PubMed ID: 14971049 [TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22-CCR4 axis. Maolake A; Izumi K; Shigehara K; Natsagdorj A; Iwamoto H; Kadomoto S; Takezawa Y; Machioka K; Narimoto K; Namiki M; Lin WJ; Wufuer G; Mizokami A Oncotarget; 2017 Feb; 8(6):9739-9751. PubMed ID: 28039457 [TBL] [Abstract][Full Text] [Related]
17. Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions. Bochner BS; Hudson SA; Xiao HQ; Liu MC J Allergy Clin Immunol; 2003 Nov; 112(5):930-4. PubMed ID: 14610482 [TBL] [Abstract][Full Text] [Related]
18. Expression and functional activity of chemokine receptors in glatiramer acetate-specific T cells isolated from multiple sclerosis patient receiving the drug glatiramer acetate. Høglund RA; Hestvik AL; Holmøy T; Maghazachi AA Hum Immunol; 2011 Feb; 72(2):124-34. PubMed ID: 20977917 [TBL] [Abstract][Full Text] [Related]
19. Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma. Tsujikawa T; Yaguchi T; Ohmura G; Ohta S; Kobayashi A; Kawamura N; Fujita T; Nakano H; Shimada T; Takahashi T; Nakao R; Yanagisawa A; Hisa Y; Kawakami Y Int J Cancer; 2013 Jun; 132(12):2755-66. PubMed ID: 23180648 [TBL] [Abstract][Full Text] [Related]
20. CCL17 and CCL22 chemokines are upregulated in human obesity and play a role in vascular dysfunction. Hueso L; Marques P; Morant B; Gonzalez-Navarro H; Ortega J; Real JT; Sanz MJ; Piqueras L Front Endocrinol (Lausanne); 2023; 14():1154158. PubMed ID: 37124725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]